Chemotherapy Dose Reductions and Dose Delays Due to Thrombocytopenia

被引：0
|
作者：
Prakash, Gautham [1 ]
Pandrangi, Kelsey [1 ]
Khateeb, Ranya [1 ]
Jain, Shivi [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-171193
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
311
引用
收藏
页码：11248 / 11249
页数：2
相关论文
共 50 条
  • [1] Incidence of Chemotherapy Dose Reductions and Dose Delays, and Reduced Chemotherapy Dose Intensity in Early Stage Breast Cancer.
    Weycker, D.
    Edelsberg, J.
    Kartashov, A.
    Barron, R.
    Lyman, G.
    CANCER RESEARCH, 2011, 71
  • [2] Dose Delays, Dose Reductions, and Relative Total Dose Intensity in Patients With Advanced Cancer Who Exercised During Neoadjuvant Chemotherapy Treatment
    Wonders, Karen Y. Y.
    Schmitz, Kathryn
    Harness, Jay
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [3] DOSE DELAYS, DOSE REDUCTIONS, AND RELATIVE TOTAL DOSE INTENSITY IN PATIENTS WITH ADVANCED CANCER WHO EXERCISED DURING NEOADJUVANT CHEMOTHERAPY TREATMENT
    Wonders, Karen
    Schmitz, Kathryn
    Harness, Jay
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : 44 - 45
  • [4] Dose delays, dose reductions, and relative dose intensity in patients with cancer who received (neo)adjuvant chemotherapy in community oncology practices
    Bhor, Menaka
    Li, Xiaoyan
    Favret, Anne
    Morrow, Phuong Khanh H.
    Denduluri, Neelima
    Barron, Richard L.
    Saravanan, Shanmugapriya
    Girardi, Vincent
    Patt, Debra A.
    Li, Yanli
    Lyman, Gary H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
    Denduluri, Neelima
    Patt, Debra A.
    Wang, Yunfei
    Bhor, Menaka
    Li, Xiaoyan
    Favret, Anne M.
    Morrow, Phuong Khanh
    Barron, Richard L.
    Asmar, Lina
    Saravanan, Shanmugapriya
    Li, Yanli
    Garcia, Jacob
    Lyman, Gary H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (11): : 1383 - +
  • [6] Dose delays, dose reductions, and relative total dose intensity in patients with advanced cancer who exercised during neoadjuvant chemotherapy treatment
    Wonders, Karen
    Schmitz, Kathryn
    Harness, Jay
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 274 - 275
  • [7] CHEMOTHERAPY DELAYS OR DOSE REDUCTIONS IN AFRICAN AMERICAN WOMEN WITH NEWLY DIAGNOSED BREAST CANCER
    Jiang, Yun
    Yee, Melissa K.
    Sereika, Susan M.
    Connolly, Mary C.
    Rosenzweig, Margaret Q.
    ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S291 - S291
  • [8] Dose delays, dose reductions, and relative dose intensity in early stage breast cancer patients receiving (neo) adjuvant chemotherapy in community oncology practices
    Favret, A. M.
    Li, X.
    Denduluri, N.
    Morrow, P. K.
    Bhor, M.
    Barron, R. L.
    Dhanda, R.
    Langeberg, W. J.
    Saravanan, S.
    Girardi, V.
    Lyman, G. H.
    CANCER RESEARCH, 2013, 73
  • [9] Chemotherapy Relative Dose Intensity and Therapy Efficacy in Hodgkin and Non-Hodgkin Lymphoma: The Effect of Dose Reductions and Delays on Cure
    Bowhay-Carnes, Elizabeth
    Fountzilas, Christos
    Martinez, Michelle Janania
    Konkel, Brandon
    Stormes, Brandon
    Karnad, Anand
    BLOOD, 2015, 126 (23)
  • [10] Adiposity, muscle mass and delays and dose reductions on adjuvant, taxane-based chemotherapy for breast cancer
    Feliciano, Elizabeth M. Cespedes
    Lee, Valerie
    Chen, Wendy Y.
    Prado, Carla M.
    Shachar, Shlomit S.
    Alexeeff, Stacey
    Caan, Bette J.
    CANCER RESEARCH, 2019, 79 (13)
12345